Double bottom in GILDWonderful double bottom pattern spotted in GILD. It hasn't broken out yet. This chart is for educational purposes only. Please consult your financial advisor before making any buy or sell decision.
4.11EUR
5.13 BEUR
24.51 BEUR
1.25 B
About GILEAD SCIENCES
Sector
Industry
CEO
Daniel P. O'Day
Website
Headquarters
Foster City
Employees (FY)
18 K
Founded
1987
ISIN
US3755581036
FIGI
BBG00J7BM5F4
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Gildgilead science is in parallel channel since last 6 years and forming bearish downward pattern.
This is not good as follow through for the long pole is missing.
Manage risks and Own profitsHere's a rotated Trade Box For GLD
PLease refere to old trade boxes to get a keymap or feel free to PM!
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 1GILD is featured.
Frequently Asked Questions
The current price of 1GILD is 62.01 EUR — it has decreased by 1.71% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange GILEAD SCIENCES stocks are traded under the ticker 1GILD.
GILEAD SCIENCES is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
1GILD stock is 2.05% volatile and has beta coefficient of 0.47. Check out the list of the most volatile stocks — is GILEAD SCIENCES there?
One year price forecast for GILEAD SCIENCES has a max estimate of 113.97 EUR and a min estimate of 64.99 EUR.
1GILD earnings for the last quarter are 2.17 EUR whereas the estimation was 1.81 EUR which accounts for 19.50% surprise. Estimated earnings for the next quarter are 1.59 EUR. See more details about GILEAD SCIENCES earnings.
GILEAD SCIENCES revenue for the last quarter amounts to 6.67 B EUR despite the estimated figure of 6.44 B EUR. In the next quarter revenue is expected to reach 6.43 B EUR.
Yes, you can track GILEAD SCIENCES financials in yearly and quarterly reports right on TradingView.
1GILD stock has fallen by 2.91% compared to the previous week, the month change is a 8.40% fall, over the last year GILEAD SCIENCES has showed a 18.62% decrease.
1GILD net income for the last quarter is 1.29 B EUR, while the quarter before that showed 2.06 B EUR of net income which accounts for −37.22% change. Track more GILEAD SCIENCES financial stats to get the full picture.
Today GILEAD SCIENCES has the market capitalization of 78.21 B, it has decreased by 4.38% over the last week.
Yes, 1GILD dividends are paid quarterly. The last dividend per share was 0.71 EUR. As of today, Dividend Yield (TTM)% is 4.51%. Tracking GILEAD SCIENCES dividends might help you take more informed decisions.
GILEAD SCIENCES dividend yield was 3.70% in 2023, and payout ratio reached 66.62%. The year before the numbers were 3.40% and 80.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 1GILD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GILEAD SCIENCES stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 18.00 K employees. See our rating of the largest employees — is GILEAD SCIENCES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GILEAD SCIENCES technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GILEAD SCIENCES stock shows the strong sell signal. See more of GILEAD SCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GILEAD SCIENCES future price: according to them, 1GILD price has a max estimate of 113.97 EUR and a min estimate of 64.99 EUR. Read a more detailed GILEAD SCIENCES forecast: see what analysts think of GILEAD SCIENCES and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GILEAD SCIENCES EBITDA is 10.76 B EUR, and current EBITDA margin is 45.96%. See more stats in GILEAD SCIENCES financial statements.